An evaluation of culture results during treatment for tuberculosis as surrogate endpoints for treatment failure and relapse. by Patrick P J Phillips, Katherine Fielding, Andrew J Nunn

Get full text

Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape. by Patrick P J Phillips, Carole D Mitnick, James D Neaton, Payam Nahid, Christian Lienhardt, Andrew J Nunn

Get full text

Proposals on Kaplan–Meier plots in medical research and a survey of stakeholder views: KMunicate by Christopher I Jarvis, Tim P Morris, William Cragg, Patrick P J Phillips, Babak Choodari-Oskooei, Matthew R Sydes

Get full text

The Impact of a Line Probe Assay Based Diagnostic Algorithm on Time to Treatment Initiation and Treatment Outcomes for Multidrug Resistant TB Patients in Arkhangelsk Region, Russia... by Platon Eliseev, Grigory Balantcev, Elena Nikishova, Anastasia Gaida, Elena Bogdanova, Donald Enarson, Tara Ornstein, Anne Detjen, Russell Dacombe, Elena Gospodarevskaya, Patrick P J Phillips, Gillian Mann, Stephen Bertel Squire, Andrei Mariandyshev

Get full text

Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options... by Allan Musinguzi, Joan R Kasidi, Jillian L Kadota, Fred Welishe, Anne Nakitende, Lydia Akello, Jane Nakimuli, Lynn T Kunihira, Bishop Opira, Yeonsoo Baik, Devika Patel, Amanda Sammann, Christopher A Berger, Hélène E Aschmann, Payam Nahid, Robert Belknap, Moses R Kamya, Margaret A Handley, Patrick P J Phillips, Noah Kiwanuka, Achilles Katamba, David W Dowdy, Adithya Cattamanchi, Fred C Semitala, Anne R Katahoire

Get full text

ACTG A5409 (RAD-TB): Study protocol for a phase 2 randomized, adaptive, dose-ranging, open-label trial of novel regimens for the treatment of pulmonary tuberculosis by Linda J. Harrison, Gustavo E. Velásquez, Russell R. Kempker, Marjorie Z. Imperial, Eric Nuermberger, Susan E. Dorman, Elisa Ignatius, Janeway Granche, Patrick P. J. Phillips, Jennifer Furin, Eunsol Yang, Colleen Foley, Shawn Chiambah, Rochelle Rogers, Austin Van Grack, Jhoanna Roa, Justin Shenje, Sandy Nerette, Cecilia Kanyama, Rachel Bakyayita Kyeyune, Alberto Mendoza-Ticona, William Murtaugh, Salah Foraida, Melanie Goth, Andrew Vernon, Kelly E. Dooley, Radojka M. Savic

Get full text

Author Correction: Risk-stratified treatment for drug-susceptible pulmonary tuberculosis by Vincent K. Chang, Marjorie Z. Imperial, Patrick P. J. Phillips, Gustavo E. Velásquez, Payam Nahid, Andrew Vernon, Ekaterina V. Kurbatova, Susan Swindells, Richard E. Chaisson, Susan E. Dorman, John L. Johnson, Marc Weiner, Amina Jindani, Thomas Harrison, Erin E. Sizemore, William Whitworth, Wendy Carr, Kia E. Bryant, Deron Burton, Kelly E. Dooley, Melissa Engle, Pheona Nsubuga, Andreas H. Diacon, Nguyen Viet Nhung, Rodney Dawson, Radojka M. Savic, AIDS Clinical Trial Group, Tuberculosis Trials Consortium

Get full text

Risk-stratified treatment for drug-susceptible pulmonary tuberculosis by Vincent K. Chang, Marjorie Z. Imperial, Patrick P. J. Phillips, Gustavo E. Velásquez, Payam Nahid, Andrew Vernon, Ekaterina V. Kurbatova, Susan Swindells, Richard E. Chaisson, Susan E. Dorman, John L. Johnson, Marc Weiner, Amina Jindani, Thomas Harrison, Erin E. Sizemore, William Whitworth, Wendy Carr, Kia E. Bryant, Deron Burton, Kelly E. Dooley, Melissa Engle, Pheona Nsubuga, Andreas H. Diacon, Nguyen Viet Nhung, Rodney Dawson, Radojka M. Savic, AIDS Clinical Trial Group, Tuberculosis Trials Consortium

Get full text